Outsourcing Oncology Manufacturing: Benefits, Risks & What Pharma Companies Should Know
Introduction The global oncology pharmaceutical market is expanding rapidly as cancer therapies continue evolving across targeted therapies, biologics, immunotherapies, and sterile injectable formulations. As oncology drug pipelines become more specialized and manufacturing complexity increases, pharmaceutical companies are increasingly turning to outsourcing models to accelerate commercialization, reduce infrastructure costs, and improve scalability. This shift has significantly […]